SCHEMBL2677332

SCHEMBL2677332

CCC(C)(C)c1ccc(C([NH])=O)c(C(C)(C)CC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 6/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
NPSR1 Q6W5P4 5/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
LMNA P02545 1/20 0.41
CASP3 P42574 1/20 0.41
ATM Q13315 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
RXRA P19793 5/20 0.37
PPARG P37231 5/20 0.37
RARG P13631 4/20 0.37
MAPT P10636 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10705380 0.78 MAPK1 (0.45) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL14354731 0.78 MAPK1 (0.45) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL15457984 0.78 MAPK1 (0.47) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL29630093 0.78 MAPK1 (0.47) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL778350 0.78 MAPK1 (0.47) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL27557016 0.77 MAPK1 (0.46) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL8145475 0.76 MAPK1 (0.59) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL11134485 0.76 MAPK1 (0.49) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL8407030 0.75 MAPK1 (0.58) MAPK1SMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL12918504 0.75 MAPK1 (0.46) MAPK1SMN1; SMN2NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1975160-B1 Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method FUJIFILM CORP (JP) 2013-01-16 EP disclosed
US-8173226-B2 Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 US disclosed
EP-2093265-A1 Inkjet ink composition, and inkjet recording method and printed material employing same FUJIFILM Corporation (JP) 2009-08-26 EP disclosed
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
EP-1975160-A1 Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method Fujifilm Corporation (JP) 2008-10-01 EP disclosed
US-7022823-B2 Diazonium salt, its synthesizing method and recording material FUJI PHOTO FILM CO., LTD. (JP) 2006-04-04 US disclosed
US-20040039180-A1 Diazonium salt, its synthesizing method and recording material FUJI PHOTO FILM CO., LTD. 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD CNOT1, CCNT1, SCO2 MAPK1 47/4885SMN1; SMN2 1372/4885NPSR1 3589/4885
US-20040039180-A1 Diazonium salt, its synthesizing method and recording material CACNA1E, HCN2, HCN1 MAPK1 442/4885SMN1; SMN2 745/4885NPSR1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.